Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Latest cGMP manufacturing Stories

2013-12-03 12:25:52

Strategic Alliance to Provide Seamless Services from Cell Line Development to cGMP Manufacturing of Biologic Drugs HSINCHU, Taiwan and GENEVA, Dec. 3, 2013 /PRNewswire/ -- JHL Biotech, Inc., a provider of biopharmaceutical process development and manufacturing services, and Switzerland-based Selexis SA, a provider of technologies for mammalian cell line development, announced today that they have signed a non-exclusive strategic agreement to provide biopharmaceutical customers a seamless...

2013-11-11 08:28:00

SAN DIEGO and SAN ANTONIO, Nov. 11, 2013 /PRNewswire/ -- Formex, LLC ("Formex"), a leader in small molecule formulation and clinical trial manufacturing, announced at the 2013 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting & Exposition in San Antonio, TX the validation and launch of its dedicated suites for R&D and cGMP production capabilities of cytotoxic and potent pharmaceuticals. (Logo: http://photos.prnewswire.com/prnh/20130718/MM49948LOGO)...

2013-11-05 08:36:07

SAN DIEGO, Nov. 5, 2013 /PRNewswire/ -- Pfenex Inc. today announced that it has awarded Paragon Bioservices a contract for the current Good Manufacturing Practice (cGMP) manufacturing of its rPA based anthrax vaccine. Paragon Bioservices will implement the cGMP-ready Pfenex Expression Technology(TM)-based production process that has been developed at Pfenex, through its vaccines division. Funding will be provided by the Department of Health and Human Services (HHS), through the...

2013-07-19 08:26:33

SAN DIEGO, July 19, 2013 /PRNewswire/ -- Biotech Investment Group. LLC ("BiG") and Formex, LLC ("Formex") announced today that BiG recently completed the asset purchase of PharmaForm and launched Formex, LLC, a leader in small molecule formulation for the pharmaceutical and biotechnolgy industry. (Logo: http://photos.prnewswire.com/prnh/20130718/MM49948LOGO) Having acquired the assets of PharmaForm, the Biotech Investment Group began operations of its newly created subsidiary,...

2012-10-24 15:25:22

In the news release, Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen, issued 24-Oct-2012 by Pfenex Inc. over PR Newswire, we are advised by the company that in the third paragraph, the last sentence should have been a quote attributed to Dr. Annie Mo. This quote is now the fourth paragraph. The complete, corrected release follows: Pfenex Inc. Awards Althea Technologies a Contract for cGMP...

2012-10-24 07:30:36

SAN DIEGO, Oct. 24, 2012 /PRNewswire/ -- Pfenex Inc. today announced that it has awarded Althea Technologies a contract for the current Good Manufacturing Practice (cGMP) manufacturing of circumsporozoite protein (CSP) from Plasmodium falciparum, an important and proven component of an effective malaria vaccine. Althea Technologies will implement the cGMP-ready Pf?nex Expression Technology(TM)-based production process that was developed at Pfenex over the past several months. Processes for...